3 Penny Stocks to Add to Your Watchlist in April
There is no simple answer to the question of whether penny stocks are a good investment or not. It depends on a variety of factors, including the current state of the economy, the company’s financial stability, and your own personal financial goals. If you’re looking to invest in penny stocks, it’s important to do your research and understand the risks involved.
Penny stocks are often more volatile and less predictable than blue chips. This is due to the under $5 price tag of penny stocks, and the frequency at which they move. While some investors are looking for long term stocks to buy, those who trade penny stocks tend to appreciate the high degree of volatility involved.
In addition to this, investing in penny stocks can also offer the potential for greater rewards. If you’re willing to take on the risks, investing in penny stocks can be great a way to make big profits in the stock market. Now, it’s also worth considering that the risks with penny stocks are also much higher than blue chips. Just as easily as you can make money with small caps, you can lose it as well. some examples of big movers right now include Clever Leaves Holdings Inc. (NASDAQ: CLVR) and Aileron Therapeutics Inc. (NASDAQ: ALRN), among others.
Ultimately, the decision of whether or not to invest in penny stocks depends on your own financial goals and risk tolerance. If you’re willing to take on more risk for the potential of greater rewards, penny stocks may be a good investment for you. However, if you’re looking for a more stable investment, blue chip stocks may be a better option. With this in mind, let’s take a look at three penny stocks that you should add to your watchlist in April.
3 Penny Stocks to Watch in April 2022
- Creative Medical Technology Holdings Inc. (NASDAQ: CELZ)
- ADMA Biologics Inc. (NASDAQ: ADMA)
- Agrify Corp. (NASDAQ: AGFY)
Creative Medical Technology Holdings Inc. (NASDAQ: CELZ)
CELZ stock is a penny stock that we have discussed numerous times in the past few weeks. And today during trading, shares of CELZ managed to shoot up by over 9.2% at EOD. This gives it a staggering five day gain of almost 100%.
The biggest recent news for Creative Medical came a few days ago when it announced positive top-line results from its StemSpine pilot study. In the study, the company states that two-year follow up data showed significant efficacy and no serious effects from using the treatment. For some context, StemSpine is a procedure that uses a patients bone marrow to treat lower back pain.
“The positive two-year data from our StemSpine pilot study are very encouraging, and we are excited to engage with practitioners on commercialization.
To our knowledge, this pilot is the first demonstration of the clinical efficacy of injecting bone marrow aspirate in areas surrounding the disc, thereby repairing, remodeling and improving the blood supply around the disc and lower back area.”Timothy Warbington, the President and CEO of Creative Medical
This is all great news and comes at a time when investors continue to look at the biotech industry for its potential. So, whether CELZ stock is worth adding to your penny stocks watchlist or not is up to you.
ADMA Biologics Inc. (NASDAQ: ADMA)
ADMA Biologics is another penny stock that is seeing significant bullish momentum right now. At EOD on March 25th, shares of ADMA stock had shot up by over 7.6%. This is a big gain and shows a 31% gain for ADMA in the past six months. So, why are shares of ADMA stock climbing right now?
The biggest news from the company came in its Q4 and full year financial results, which it reported yesterday. In the results, the company posted total revenue for the year of $81 million. This represents a 92% increase YoY. Additionally, the company managed to complete a $175 million debt refinancing deal with Hayfin Capital Management.
“The 2021 financial results of 92% revenue growth and positive gross margin signify that our investments are yielding returns for the Company. As evidenced by the improving gross profits and narrowing net losses, we are particularly encouraged by the recent uptick in ASCENIV™ utilization by prescribers.”The CEO of ADMA Biologics, Adam Grossman
The most encouraging aspect of these results is the advantageous financial and growth numbers that ADMA is showing. Because of this, ADMA stock could be worth adding to your list of penny stocks to watch.
Agrify Corp. (NASDAQ: AGFY)
Agrify Corp. is one of the largest gainers on March 25th, pushing up by more than 19% at EOD. This gain comes only a day after shares of AGFY stock shot down by over 20%. In the past six months, AGFY stock has dropped in value by almost 80%. So, today’s gain is a welcomed advance from that. Now, the main reason for the recent bearish sentiment with AGFY stock came when it announced its earnings on March 23rd. In the report, it posted revenue growth in 2021 of 395% over the previous year to $59.9 million. In addition, Q4 revenue grew 481% YoY to $25.3 million.
“During 2021, we drove significant year-over-year growth, launched our Total Turn-Key Solution for cannabis cultivators, created a significant backlog of future high-margin recurring revenues, drove tremendous pipeline velocity, implemented innovative technological advancements to our Vertical Farming Unit, and established ourselves as the leader in premium extraction solutions through a series of well-executed acquisitions.”The CEO of Agrify, Raymond Chang
With these exciting results, it’s tough to see why shares of AGFY stock have been dropping. Despite this, it could be worth considering as a penny stock to watch this coming month.
Are Penny Stocks Worth Buying Right Now?
The answer of whether penny stocks are worth buying or not depends completely on your trading strategy and investment goals. While some may find value in penny stocks, others may believe that they are too risky to invest in.
Regardless, knowing what type of trader you are, and how to take advantage of that preference is crucial. Considering this, do you think that penny stocks are worth buying right now or not?